Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
116.62
+2.52 (2.21%)
At close: Sep 17, 2025, 4:00 PM EDT
117.69
+1.07 (0.92%)
After-hours: Sep 17, 2025, 6:09 PM EDT
Axsome Therapeutics Employees
Axsome Therapeutics had 683 employees as of December 31, 2024. The number of employees increased by 138 or 25.32% compared to the previous year.
Employees
683
Change (1Y)
138
Growth (1Y)
25.32%
Revenue / Employee
$724,792
Profits / Employee
-$361,493
Market Cap
5.82B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 683 | 138 | 25.32% |
Dec 31, 2023 | 545 | 162 | 42.30% |
Dec 31, 2022 | 383 | 275 | 254.63% |
Dec 31, 2021 | 108 | 48 | 80.00% |
Dec 31, 2020 | 60 | 15 | 33.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AXSM News
- 13 hours ago - Axsome Therapeutics Highlights Data Across Its Leading Neuroscience Pipeline at Psych Congress 2025 - GlobeNewsWire
- 9 days ago - Axsome Therapeutics, Inc. (AXSM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 21 days ago - Axsome Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Axsome Therapeutics Analysts Increase Their Forecasts After Q2 Earnings - Benzinga
- 6 weeks ago - Axsome Therapeutics, Inc. (AXSM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Axsome Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Axsome: Some Recent Setbacks, Some Recent Wins -- Still A Buy - Seeking Alpha
- 2 months ago - Axsome Therapeutics Hosts Frontiers in Brain Health R&D Day Reviewing Industry-Leading Late-Stage CNS Pipeline - GlobeNewsWire